Author Archive for bdellerin

24
Nov

Twittering moms take down Motrin…and McNeil acts responsibly

I really wanted to like the online Motrin ads that caused so much fury among mothers last week. Living in Park Slope, I have seen many pretty innocuous matters get blown out of proportion. So I went to YouTube to watch the ad. And you know what? The moms were right. The ad is dopey.

Motrin adFor those who haven’t seen it, here’s a synopsis. The ad focuses on moms who carry their babies in slings, Bjorns, carriers. The ad’s theory is that women who transport their children this way tend have more aches and pains. To begin with, the concept is flawed because if the carrier fits well, then you won’t have such problems.

The ad starts off in a smarmy way poking fun at the whole mommy transport system with “Wearing your baby seems to be in fashion,” and goes downhill from there. Here are my favorite lines:

  • “They say babies carried close to the bod tend to cry less than others. But what about me? Do moms that wear babies cry more?” [BE note: Believe me, I cried a lot in the early days but it wasn't because of my Baby Bjorn."]
  • “Plus it totally makes me look like an official mom.” [BE note: What's up with the Valley speak?]
  • “So if I look tired and crazy you’ll understand why.” [BE note: crazy? OK now.]

twitterThere are many things wrong with the ad but they’ve been covered admirably on Twitter and blogs. In fact it was because a number of women on Twitter balked at the ad that its offensiveness was brought to McNeil’s [maker of Motrin] attention.

But there is more to it. McNeil has not gotten much positive press about acting responsibly once the Twittering and blogging started. So I’m giving them some. They took down the ad, apologized via JNJ BTW (J&J’s corporate blog), and basically did the right thing by owning up to their error. How many times does that ever happen in real life?

I encourage you to read Kathy Widmer’s post on JNJ BTW. Kathy is VP marketing for McNeil Consumer Healthcare. Here is one excerpt:

jnjbtw“On behalf of McNeil, I’m sorry if you found this advertisement insulting. We are are in the process of removing it from our website. Unfortunately, it will take longer for us to remove this advertisement from magazines as several are currently on newsstands and in distribution.

One bright spot is that we have learned through this process - in particular, the importance of paying close attention to the conversations that are taking place online. It has also brought home the importance of taking a broader look at what we say and how it may be interpreted.”

So power to the people, power to social media and power to doing the right thing!

03
Nov

A breast cancer community of their own

Today we profile a real-life example of Big Pharma supporting patient education and interaction through social media. Bristol-Myers Squibb provided unrestricted funding to facilitate the launch of a new site for women with advanced breast cancer.

The Advanced Breast Cancer Community launched in early September offering both an information gateway and social network for the advanced/metastatic breast cancer community. Why another site dedicated to cancer? Because those living with advanced breast cancer have had no single site to call their own. A wealth of information exists for these women but it is often buried within sites making it cumbersome and exhausting to find.

The new site is their gateway. As one user commented, “Early on in my diagnosis I perused many Internet sites that just left me more confused, scared and depressed than I already was. So I gave up looking. Until something brought me to this site just yesterday. What a great place. I can tell already that this is the place where I want to hang out.”

The Advanced Breast Cancer Community is built on tools from Inspire, a company that creates and manages online health communities in partnership with dozens of leading nonprofits, e.g. Arthritis Foundation, WomenHeart, National Osteoporosis Foundation.

Perhaps the most impressive thing about the initiative is that it involved buy-in from 13 non-profit organizations! See the list of participating breast cancer patient advocacy organizations below.

AdvancedBC.org
Breast Cancer Network of Strength (formerly Y-Me)
Breastcancer.org
Breast Cancer Research Foundation
CancerCare
The Linda Creed Foundation
Living Beyond Breast Cancer
Metastatic Breast Cancer Network
SHARE
Sisters’ Network
Susan G. Komen for the Cure
The Wellness Community
Young Survival Coalition

28
Oct

Scientific symposia going virtual

Attending clinical conferences online is gaining in popularity, and with the economy teetering on the brink it’s not hard to figure out why. In a recent ePharma report from Manhattan Research, the author pointed out that virtual conferences attendance has grown at a double-digit rate over the past three years.

To capture some of the expected dollars that will likely flow in this direction, media giant HAVAS (parent of Euro RSCG Life) has launched Havas Drive to create virtual symposia environments. They are partnering with WebMD’s Medscape to market their first offering, “Virtual Convention Booth,” to pharma companies. In the works are Virtual Detail, which will enable a virtual sales rep to deliver a detail in a 3-D environment, and Virtual Hospital, a simulation tool aimed at teaching hospital staff how to optimize patient care.

20
Oct

More on Revolution…and consumers’ favorite pharma sites

Last week I wrote about the Revolution-Waterfront merger. If you’d like more perspective on the deal, there is an excellent interview on the Health Business Blog between David Williams and Mark Bard, CEO of Manahttan Research.

Recently I highlighted the top 10 pharma sites visited by PCP’s (Manhattan Research). Now comScore, Inc. has released its own study of the top pharmaceutical brand sites, but this one is based on all users, not physicians only, and is period specific. Thus not apples to apples. That said, it is interesting to note that there is not much crossover between the two studies. Only three sites appear on both: Actos, Gardasil and Januvia.

Top 10 Pharmaceutical Brand Web Sites by Unique Visitors
Q2 2008 vs. Q2 2007
Total U.S. – Home/Work/University Locations

  1. Nexium - 1,021,000 (up 55% from 2Q 2007)
  2. Actos - 855,000 (+2399%)
  3. Ambien CR - 756,000 (-61%)
  4. Gardasil - 722,000 (-21%)
  5. Lexapro - 549,000 (+3%)
  6. Veramyst - 538,000 (launched in 08)
  7. Januvia - 507,000 (+329%)
  8. Lyrica - 501,000 (+36%)
  9. Topamax - 498,000 (+38%)
  10. Seroquel - 447,000 (+24%)

Some highlights from the study:

Takeda substantially increased marketing for the Actos brand beginning in 3Q 2007, helping build actos.com into the second most visited site in the category.

Pfizer has boosted marketing and public relations efforts for Lyrica since 3Q 2007, when the product was approved for the treatment of fibromyalgia.

Diabetes drug Januvia recorded a 330% increase in visitors to its site after Merck increased marketing activity in the second half of 2007.

10
Oct

The Revolution has washed up

Steve Case was going to change healthcare forever. “Our mission is to revolutionize the health-care system,” he said in an interview upon Revolution Health’s debut in 2007. For those of us who have been around the healthcare block a few times, we usually roll our eyes when someone with no background jumps into the fray promising to “fix” everything that ails healthcare. Well it’s over for Steve and he didn’t quite overhaul the system.

Late last week, Revolution Health announced its intention to merge with NY-based Waterfront Media, home to Everyday Health and multiple diet-related sites like the South Beach Diet and My Calorie Counter. The combined company will host 24 health and wellness sites and operate under the Waterfront umbrella with Benjamin Wolin, current Waterfront CEO, at the helm. Case will join the board.

The deal puts Waterfront in a solid position to compete with WebMD. According to comScore Media Metrix, Everyday Health was the second most popular health site in July 2008, with 14.7 million unique visitors and the Revolution Health sites came in third, with 11.3 million visitors. The NY Times valued the deal at $300 million.